文献速递消化道肿瘤与早癌消化内镜

巴西基于粪便免疫化学检测的大肠癌筛查可行性与结肠镜检出率

Feasibility and Colonoscopy Yield Using the Fecal Immunochemical Test (FIT)-Based Colorectal Cancer Screening in a Latin America Country.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-02-09

在巴西圣保罗开展前瞻性人群研究,邀请9881名50-75岁无症状个体接受FIT筛查,阳性者转诊结肠镜。FIT阳性率7.8%,结肠镜依从性68.9%,检出CRC 5.9%、进展期腺瘤31.4%、进展期肿瘤33.0%,年龄与CRC正相关,FIT浓度越高检出率越高。

要点

  • FIT阳性率7.8%,结肠镜依从性68.9%
  • FIT阳性者中CRC检出5.9%,进展期肿瘤33.0%
  • 年龄与CRC正相关,FIT浓度越高肿瘤检出率越高

核心结论

  • 在低资源环境下实施基于FIT的大肠癌筛查项目可行,FIT阳性者肿瘤检出率高。

研究设计与样本

  • 前瞻性人群研究,纳入巴西圣保罗9881名50-75岁无症状个体,FIT阳性(≥10 μg Hb/g粪便)者转诊结肠镜。

主要发现

  • FIT阳性率为7.8%,结肠镜依从性为68.9%(n=535)。
  • FIT阳性者中CRC检出率为5.9%,腺瘤为63.2%,进展期腺瘤为31.4%,进展期肿瘤为33.0%。
  • 年龄与CRC呈正相关(P = .03)。
  • FIT浓度越高,CRC(P < .008)、进展期腺瘤(P < .001)和进展期肿瘤(P < .001)检出率越高。
  • 波士顿量表充分率为99%,盲肠插管率为99.4%。

临床怎么用

  • 该模式可作为巴西及拉丁美洲规划和推广组织性大肠癌筛查的参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Organized colorectal cancer (CRC) screening is not widely practiced in Latin America and the results of regional studies may help overcome barriers for implementation of national screening programs. We aimed to describe the implementation and findings of a fecal immunochemical test (FIT)-based program in Brazil. METHODS: In a prospective population-based study, asymptomatic individuals (50-75 years old) from Sao Paulo city were invited to undergo FIT for CRC screening. Participants with positive FIT (≥10 μg Hb/g feces) were referred for colonoscopy. Subjects were classified into groups according to the presence of CRC, precursor lesions, and other benign findings, possibly related to bleeding. RESULTS: Of a total of 9881 subjects, 7.8% had positive FIT and colonoscopy compliance was 68.9% (n = 535). Boston scale was considered adequate in 99% and cecal intubation rate was 99.4%. CRC was diagnosed in 5.9% of the cases, adenoma in 63.2%, advanced adenoma in 31.4%, and advanced neoplasia in 33.0%. Age was positively associated with CRC (P = .03). Higher FIT concentrations were associated with increased detection of CRC (P < .008), advanced adenoma (P < .001), and advanced neoplasia (P < .001). CONCLUSIONS: Implementation of a FIT-based CRC screening program was feasible in a low-resource setting, and there was a high yield for neoplasia in individuals with a positive FIT. This approach could be used as a model to plan and disseminate organized CRC screening more broadly in Brazil and Latin America.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Sorbello MP, Ribeiro Júnior U, Eluf-Neto J, et al. Feasibility and Colonoscopy Yield Using the Fecal Immunochemical Test (FIT)-Based Colorectal Cancer Screening in a Latin America Country. Clin Gastroenterol Hepatol. 2024. PMID: 38342277. doi:10.1016/j.cgh.2024.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。